Biogen Launches Lucentis Biosimilar Byooviz In Canada

As Natco Introduces First Pomalyst Generic Approved By Health Canada

 
• By David Wallace
  
Canada flag eye
Byooviz is the first Lucentis biosimilar launched in Canada • Source: Bo Valentino / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin